More Immutep Ltd news Immutep LtdASX: IMM Approval to start Efti & Bavencio trial in urothelial cancer May 1, 2023 at 2:32 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
